Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Moleculin Biotech Inc (NASDAQ: MBRX) was $0.57 for the day, up 1.27% from the previous closing price of $0.57. In other words, the price has increased by $1.27 from its previous closing price. On the day, 1.08 million shares were traded. MBRX stock price reached its highest trading level at $0.589 during the session, while it also had its lowest trading level at $0.56.
Ratios:
Our analysis of MBRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 23 ’25 when Foster Jonathan P. bought 270,270 shares for $0.37 per share. The transaction valued at 100,000 led to the insider holds 287,587 shares of the business.
KLEMP WALTER V bought 675,675 shares of MBRX for $250,000 on Jun 23 ’25. The CEO and President now owns 743,607 shares after completing the transaction at $0.37 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBRX now has a Market Capitalization of 17408508 and an Enterprise Value of 10053429.
Stock Price History:
The Beta on a monthly basis for MBRX is 1.52, which has changed by -0.7672065 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, MBRX has reached a high of $3.65, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 0.15%, while the 200-Day Moving Average is calculated to be -53.61%.
Shares Statistics:
MBRX traded an average of 5.45M shares per day over the past three months and 1210120 shares per day over the past ten days. A total of 30.21M shares are outstanding, with a floating share count of 27.64M. Insiders hold about 8.74% of the company’s shares, while institutions hold 6.67% stake in the company. Shares short for MBRX as of 1753920000 were 4062686 with a Short Ratio of 0.75, compared to 1751241600 on 3443171. Therefore, it implies a Short% of Shares Outstanding of 4062686 and a Short% of Float of 13.5.
Earnings Estimates
The dynamic stock of Moleculin Biotech Inc (MBRX) is currently being evaluated by a team of 2.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.22 and low estimates of -$0.42.
Analysts are recommending an EPS of between -$5.28 and -$5.28 for the fiscal current year, implying an average EPS of -$5.28. EPS for the following year is -$4.85, with 1.0 analysts recommending between -$4.85 and -$4.85.
